最新发布
Argentina’s SENASA Streamlines Pesticide Approvals for Minor Crops and Drone Application
30 September 2026, Argentina: Argentina’s agricultural health authority, SENASA, has created a fast-track administ…
Bird Flu Returns Early to Minnesota, Catching Poultry Industry Off Guard
30 September 2026, Minnesota: Highly pathogenic avian influenza (HPAI) has resurfaced in Minnesota well ahead of its usu…
Invisible, Indispensable: Why COP31 Must Put Microbial Ecosystems on the Climate Agenda
Author: Dr Kanika Chowdhary, Associate Fellow, Social Transformation & CSR, TERI and Dr Mayurika Goel, Fellow, Susta…
Arevo Reports Corn Yield Results From Reduced-Nitrogen Field Trials
30 September 2026, Sweden: Arevo has released results from independent field trials evaluating its Arginex Corn seed tre…
India Sets 177.72 Million Tonne Rabi Target as El Niño and Rainfall Risks Persist
30 September 2026, New Delhi: India has set a 177.72 million tonne (MT) foodgrain production target for the Rabi se…
Brazil Clears First Ascaroside Biofungicide for Soybean Rust, Corn Blight
30 September 2026, São Paulo: Brazilian regulators have approved Phytalix, a biological fungicide built on a new class o…
Exclusive: ArkeaBio raises $15m for livestock methane tech, cuts headcount
ArkeaBio—a Boston-based startup developing a vaccine to cut livestock methane emissions—has raised a $15 million Series …
Skinified body care taps multifunctionality and gourmand fragrances
Body care brands are tapping multifunctionality and mood-boosting trends through new product launches in the US. Nivea has launched its Smooth & Glow Body Milk, combining hero ingredients like niacinamide and hyaluronic acid to deliver 72 hours of “deep moisture” at an affordable price point.
BASF confirms Evonik takeover talks as initial offer reportedly falls flat
BASF has confirmed talks over a potential takeover of its specialty chemicals competitor Evonik. The move could reshape Europe’s cosmetic ingredients supply base, consolidating two of the region’s largest suppliers of skin care actives, emollients, and surfactants.
AstraZeneca boards the PD-1/VEGF ship with $2B Summit investment
Why it matters: The partnership gives AstraZeneca a route to combine its tumor-targeting drugs with a closely watched next-generation immunotherapy. Summit gains funding and a major development partner while retaining its rights to ivonescimab.